Pericardial cyst rupture mimicking acute aortic syndrome.

opinion on the implementation of the SIGN guideline for heart failure. Scott Med J 2004;49:10–13. 24. Leslie SJ, McKee SP, Imray EA, Denvir MA. Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract. Postgrad Med J 2005; 81:321–326. 25. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL, Olofsson B, Ostergren J, Yusuf S, for the CHARM Investigators Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet 2003;362:759–766. 26. McMurray JJV, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA, for the CHARM Investigators Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767–771. 27. Fonarow GC, Yanct CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, Mehra M, O’Connor CM, Reynolds D, Walsh MN. Improving the use of evidencebased heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J 2007;154:12–38.